Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Dx Discovery Inc. currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The case is handled by examiner LAURA ANN ESSEX, who is the distinct examiner and the distinct art unit involved.
LAURA ANN ESSEX is the busiest examiner with 1 pending office action. With the distinct art unit active, the prosecution strategy is concentrated on a single technical review, making the feedback from the examiner critical for the portfolio's progress.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ESSEX, LAURA ANN | 1 | 60.0% | +35.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18510115 | METHODS AND COMPOSITIONS FOR PERTUSSIS DIAGNOSIS | ESSEX, LAURA ANN | — |
| Art Unit | Apps |
|---|---|
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18510115 | METHODS AND COMPOSITIONS FOR PERTUSSIS DIAGNOSIS | ESSEX, LAURA ANN | 1675 | §112DP | Non-Final OA | — | Pending | Nov 15, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialDx Discovery Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Laura Ann Essex has the most, with 1 of Dx Discovery Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
